dual gip/glp-1 receptor agonist agonists: New advances for treating type-2 diabetes Dual GLP-1/GIP Agonist | Tirzepatide

Toxic metals and antioxidants: Part II

BPC-157 (Body Protection Compound-157) is a 15-amino-acid synthetic peptide gaining popularity for its supposed he aling benefits from repairing gut lining to accelerating muscle and tendon recovery

For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection

Sae-Leaw et al

Attention to your skin and judicial use of cosmetic procedures can help you look your best